Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases - Wikidata - awgldk - TriplyDB

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

http://www.wikidata.org/entity/Q28087523

about

Diagnosis and Prognostic Significance of c-Met in Cervical Cancer: A Meta-Analysis MET deregulation in breast cancer Current advances in biomarkers for targeted therapy in triple-negative breast cancer A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling.MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer.The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer.cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer Met and its ligand HGF are associated with clinical outcome in breast cancer.LncRNA Taurine-Upregulated Gene 1 Promotes Cell Proliferation by Inhibiting MicroRNA-9 in MCF-7 Cells.c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer.Clinicopathological and prognostic significance of c-Met overexpression in breast cancer.Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents.Prognostic value of c-Met overexpression in pancreatic adenocarcinoma: a meta-analysis.MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and review.Clinicopathological impacts of high c-Met expression in renal cell carcinoma: a meta-analysis and review.Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review.Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and review.Expression and Clinical Significance of Claudin-7, PDL-1, PTEN, c-Kit, c-Met, c-Myc, ALK, CK5/6, CK17, p53, EGFR, Ki67, p63 in Triple-negative Breast Cancer-A Single Centre Prospective Observational Study.Precision medicine based on tumorigenic signaling pathways for triple-negative breast cancer Prognostic impact of high c-Met expression in ovarian cancer: a meta-analysis

P2860

Q26749186-0F7AE531-8887-4E09-B07C-D97EF047DDCD Q26781054-44D7F317-6797-4EFD-8F8D-F97996194DAA Q28074202-121B4C14-35F1-4BBF-B7D2-6B7A4E4E2A86 Q30152630-8BEF3049-919A-4685-B443-C7E4767E3CC4 Q33785102-4DBC4AB9-1361-4E3E-8656-FDC71031BF8C Q35982925-D38F150E-8631-4C09-9EBE-FFB870D5A12F Q36703854-99F3960C-53D8-44BB-B789-4DDB1D3B15BB Q37392930-DE16882D-A046-4A3C-B162-8E5EE7305287 Q37547943-BB60B246-0014-476B-9172-EF651306D536 Q40858674-E37AC6AA-AEE5-4C2F-9DC8-C461F885326A Q41344857-9FC9EAB7-845E-4E07-AAC8-4D3E38996661 Q42373819-63893DAF-E2DB-45BB-8189-A26F344C0CA3 Q42700697-23A7F854-32CF-4C24-8127-885B57886FA9 Q45968290-46589D27-0E77-42B7-AD6E-270729AEAC5D Q47103399-F647A3DB-42CA-4646-8F24-5CEB701A3FD1 Q47139946-D926170D-FED0-4DE4-A2BE-B218F6D68996 Q49414583-4AE6AC31-1784-422E-8698-407ED950B0E7 Q55278765-F6082467-E730-408E-9983-39B2AFDEF19E Q57105411-EAFD6809-E7BC-411C-AFD9-5F36B2663635 Q57493808-FABA9A73-D121-475E-BD81-3387F2E087A4

P2860

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

http://www.wikidata.org/entity/Q28087523

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

@ast

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

@en

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

@nl

type

label

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

@ast

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

@en

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

@nl

prefLabel

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

@ast

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

@en

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

@nl

P1433

Q28087523-38811B30-AB1E-4901-B952-945011C7D9ED

P1476

Q28087523-6D13867A-4F07-45E9-8B4A-EC197AB13FE4

P2093

Q28087523-348AA1BF-C620-4CCC-BA08-FBA6E218E0D6

Q28087523-3589BEC3-3635-432D-943E-F27B443B85C8

Q28087523-55945B66-5834-41E3-ADF5-BB70326A1780

Q28087523-8CB34229-1DEA-4391-A948-792E0085407A

P275

Q28087523-C7E59E6C-AAB3-40B6-A37C-E6CA4EA1BD9D

P2860

Q28087523-12C249A5-E293-481F-A29F-68BD42AAF7AB

Q28087523-13D9B39F-AF89-4F69-A9AE-8A93508777E5

Q28087523-1561EEDB-A572-43BC-81F6-40955BB55E78

Q28087523-1EB74E03-11B0-416E-9F83-4CC2F4D544F3

Q28087523-1ECDE9F7-6E34-4012-A485-BD93D5B14820

Q28087523-1F9D91D9-000C-4E41-8E7C-BDC55BA1DC10

Q28087523-274937CF-8F77-4D5C-8D01-251927EEB4B4

Q28087523-27BA5582-19A7-4115-93D6-76B709DEC93A

Q28087523-2AA3EB14-2F55-494D-8A3C-E2D97C026C3F

Q28087523-2C76E82B-66FB-41BE-9C17-D6827DABC77E

P2888

Q28087523-BD7888A2-9D36-4822-A259-63B5C518C15D

P304

Q28087523-53BFDE1E-7CA8-434F-8827-0792EE693979

P31

Q28087523-D07212F2-A29B-4A43-9DC3-4D2FC4231879

Q28087523-E3DEB6A0-0581-4C5B-A71C-E104800B3B1E

Q28087523-FCE6C37C-DA71-4E3C-80EB-CA767436E66E

P3181

Q28087523-5BD0062F-283B-40EB-9763-91B111116FD2

P356

Q28087523-CDA007B7-EF53-4179-8E50-E961BAE147FD

P407

Q28087523-61131B95-BED1-4695-AAF5-1695D9C90C16

P478

Q28087523-76CDE5EE-F44A-4962-B31E-2FCF798DF2CE

P5008

Q28087523-6D9CD0F2-A072-4785-ABDA-F1292F83D73A

P577

Q28087523-2E74E9F5-B5E5-4FC3-B738-C369EC61F26B

P5875

Q28087523-E5168F53-39A8-484D-AA52-6BB171B8EDFB

P6179

Q28087523-CA845D90-550F-4D67-BC22-7ABC10C870B0

P698

Q28087523-75C441B5-E2FE-4A18-88D6-E1CF7AE867C6

P921

Q28087523-1BD2FE8D-9FDF-45D9-A67C-89365A6D370C

Q28087523-35C41084-DEEB-4A05-B494-8A83BC700F5C

Q28087523-3A957AF2-2712-4D18-A9C1-161A0A86973B

Q28087523-43B51A08-ED5B-4FB8-9291-C3D8D0018122

Q28087523-696101B5-083E-42FA-992A-32F0D4B29C2B

Q28087523-C950BD7F-9C01-4C8A-9E2B-C2394863357C

Q28087523-DA154178-EA1D-4B45-B17F-EA188A4D30F2

Q28087523-EB6E98A3-2A2A-444C-BF18-7D35CD8BD22F

Q28087523-ED2C2D40-3D56-4F4C-9D91-41B2838716FE

Q28087523-F72960D8-7793-4EBD-838D-9199DC1FBAC7

P932

Q28087523-724ABBD7-04C1-4AE5-8F75-98CCAB183CE6

P3181

P356

S13000-015-0296-Y

P1433

Diagnostic Pathology

P1476

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

@en

P2093

Huawei Zou

http://www.w3.org/2001/XMLSchema#string

Kai Li

http://www.w3.org/2001/XMLSchema#string

Shunchao Yan

http://www.w3.org/2001/XMLSchema#string

Xin Jiao

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Gene expression profiling predicts clinical outcome of breast cancer

Practical methods for incorporating summary time-to-event data into meta-analysis

HGF/SF-met signaling in the control of branching morphogenesis and invasion

Invasive growth: a MET-driven genetic programme for cancer and stem cells

Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians.

Biological subtypes of breast cancer: Prognostic and therapeutic implications.

P2888

s13000-015-0296-y

P304

62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2431393

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/S13000-015-0296-Y

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277840694

http://www.w3.org/2001/XMLSchema#string

P6179

1050969853

http://www.w3.org/2001/XMLSchema#string

P698

26047809

http://www.w3.org/2001/XMLSchema#string

P921

cell surface receptor

membrane proteins

breast neoplasm

triple negative breast neoplasm

proto-oncogene proteins

tumor biomarkers

neoplasm proteins

P932

4458003

http://www.w3.org/2001/XMLSchema#string